SentiSense Logo

SentiSense

Ctrl+K

55% OFF

Quick tip: Press

K

to search stocks

Z

ZTS

Zoetis Inc.

$115.62

+0.16 (+0.14%)

Summary

Stories

News

Metrics

Fundamentals

Holders

Full institutional holders data is a Pro feature

Upgrade

Institutional Holders

1745

tracked filers

Total Institutional Value

$31.7B

1745 holders tracked

Report Date

Q4 2025

SEC 13F-HR filing

Notable changes (1)

POLEN CAPITAL MANAGEMENT LLC reduced position by 10.7%.

HolderCategory

Shares

Value

Weight

Change

STATE STREET CORP

Index Fund

19.6M

$2.9B

--

-0.5%

STATE FARM MUTUAL AUTOMOBILE INSURANCE CO

Insurance

12.2M

$1.8B

--

--

GEODE CAPITAL MANAGEMENT, LLC

Index Fund

9.9M

$1.4B

--

+0.2%

WELLINGTON MANAGEMENT GROUP LLP

Other

8.4M

$1.2B

--

-4.0%

POLEN CAPITAL MANAGEMENT LLC

Other

7.5M

$1.1B

--

-10.7%

Data source: SEC EDGAR 13F-HR filings

Company Profile

Symbol

ZTS


Market Cap

$48.74B


IPO Date

Feb 1, 2013


CEO

--


Employees

14,500


Sector

--


Industry

PHARMACEUTICAL PREPARATIONS


Country

United States


Exchange

--

Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on) and nearly 65% from companion animal (dogs, horses, cats) products. Its USA business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.

Read More

Similar Stocks

LLY

Eli Lilly and Company

$985.08

+0.80%

PFE

Pfizer Inc.

$26.58

-1.04%

SentiSense Logo

SentiSense

Sense what the market is doing.

© 2026 Compass AI Data Services, LLC. All rights reserved.


Important Disclaimer: Compass AI Data Services, LLC provides market information, sentiment analysis, institutional flow data, and data intelligence. We do not provide investment advice, recommendations, or financial guidance. All information is for informational and educational purposes only. Users are solely responsible for their own investment decisions. Always consult a licensed financial advisor before making investment decisions.

Cookie Preferences

We use cookies to enhance your experience and analyze site traffic. Privacy Policy